scholarly journals Body mass index and risk of renal cell cancer: A dose-response meta-analysis of published cohort studies

2014 ◽  
Vol 135 (7) ◽  
pp. 1673-1686 ◽  
Author(s):  
Furan Wang ◽  
Yinghua Xu
Keyword(s):  
Body Mass Index ◽  
Cohort Studies ◽  
Body Mass ◽  
Renal Cell Cancer ◽  
Dose Response ◽  
Renal Cell ◽  
Meta Analysis ◽  
Cell Cancer

scholarly journals Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis

Oncotarget ◽  
2018 ◽  
Vol 9 (17) ◽  
pp. 13959-13970 ◽  
Author(s):  
Jiao Zhang ◽  
Qiang Chen ◽  
Zhan-Ming Li ◽  
Xu-Dong Xu ◽  
Ai-Fang Song ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Cancer Patients ◽  
Body Mass ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Meta Analysis ◽  
Cell Cancer ◽  
Postoperative Survival

scholarly journals Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sepideh Soltani ◽  
Shima Abdollahi ◽  
Dagfinn Aune ◽  
Ahmad Jayedi
Keyword(s):  
Breast Cancer ◽  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Cancer Risk ◽  
Cohort Studies ◽  
Body Mass ◽  
Dose Response ◽  
Meta Analysis ◽  
Total Cancer

AbstractAlthough obesity has been associated with an increased cancer risk in the general population, the association in patients with type 2 diabetes (T2D) remains controversial. We conducted a dose–response meta-analysis of cohort studies of body mass index (BMI) and the risk of total and site-specific cancers in patients with T2D. A systematic literature search was conducted in PubMed, Scopus, and Medline until September 2020 for cohort studies on the association between BMI and cancer risk in patients with T2D. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random effects models. Ten prospective and three retrospective cohort studies (3,345,031 participants and 37,412 cases) were included in the meta-analysis. Each 5-unit increase in BMI (kg/m2) was associated with a 6% higher risk of total cancer (RR: 1.06, 95% CI 1.01, 1.10; I2 = 55.4%, n = 6), and with a 12% increased risk in the analysis of breast cancer (RR: 1.12, 95% CI 1.05, 1.20; I2 = 0%, n = 3). The pooled RRs showed no association with prostate cancer (RR: 1.02, 95% CI 0.92, 1.13; I2 = 64.6%, n = 4), pancreatic cancer (RR: 0.97, 95% CI 0.84, 1.11; I2 = 71%, n = 3), and colorectal cancer (RR: 1.05, 95% CI 0.98, 1.13; I2 = 65.9%, n = 2). There was no indication of nonlinearity for total cancer (Pnon-linearity = 0.99), however, there was evidence of a nonlinear association between BMI and breast cancer (Pnon-linearity = 0.004) with steeper increases in risk from a BMI around 35 and above respectively. Higher BMI was associated with a higher risk of total, and breast cancer but not with risk of other cancers, in patients with T2D, however, further studies are needed before firm conclusions can be drawn.

scholarly journals Body Mass Index and Renal Cell Cancer

Epidemiology ◽  
2012 ◽  
Vol 23 (6) ◽  
pp. 821-828 ◽  
Author(s):  
Jennifer L. Beebe-Dimmer ◽  
Joanne S. Colt ◽  
Julie J. Ruterbusch ◽  
Gregory R. Keele ◽  
Mark P. Purdue ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer

scholarly journals Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

2019 ◽  
Vol 25 (13) ◽  
pp. 3839-3846 ◽  
Author(s):  
Ugo De Giorgi ◽  
Giuseppe Procopio ◽  
Diana Giannarelli ◽  
Roberto Sabbatini ◽  
Alessandra Bearz ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Systemic Inflammation ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document